Key Issues

Lilly produces medicines that meet patients’ healthcare needs. It's critical patients have access to our products which improve or, more importantly, save lives. As global debates continue regarding healthcare and pharmaceutical innovation, we’re committed to participating in the public policy process as a responsible corporate citizen.

Lilly considers stakeholder input and a variety of other factors in determining which issues are most relevant for engagement. These factors include patient needs, business strategy, public policy dialogue, and legislative debate.


Please enable your browser's JavaScript setting in order to access this site